Frazier Life Sciences X, L.P.

13D and 13G Filings

13D/G filings
13D on 1 security
Location
Seattle, WA
CIK
0001790879
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
NewAmsterdam Pharma Company N.V 13D/A Amendment 7
NAMS · N62509109
8.7% 9/22/2026
Event 9/18/2026
NewAmsterdam Pharma Company N.V 13D/A Amendment 6
NAMS · N62509109
7.7% 11/4/2025
Event 11/1/2025
NewAmsterdam Pharma Company N.V 13D/A Amendment 5
NAMS · N62509109
6.5% 8/20/2025
Event 8/18/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.